The Planning Commission on Monday released the latest poverty estimates for the country showing a decline in the incidence of poverty by 7.3 per cent over the past five years and stating that anyone with a daily consumption expenditure of Rs. 28.35 and Rs. 22.42 in urban and rural areas respectively is above the poverty line. The new poverty estimates for 2011-12 will only add to the furore triggered by the...

-Rediff.com Opposition parties on Tuesday raised the issue of Planning Commission reducing the number of people living below the poverty line dubbing it as a ploy to deceive the poor. Soon after the Rajya Sabha met for the day, members from Bharatiya Janata Party, Janata Dal-United, Bahujan Samaj Party, All India Anna Dravida Munnettra Kazhagam and the Left parties were on their feet seeking a discussion on the issue. Chairman Hamid Ansari said...

The Centre on Saturday asserted that adequate funds were available during the2012-13 financial year to meet job demands by Below Poverty Line (BPL) households under the Mahatma Gandhi NREGS. Union Minister of Rural Development Jairam Ramesh underlined that he has recommended reallocation of funds for rural development, especially fordrinking water and sanitation projects, to ensure inclusive growth and reflect the percolation of the high growth rate to the rural side. At the...

-The Hindu The budget focuses on rural development with a moderate hike in allocation, but the government has downsized in a big way the importance of its flagship programme, the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), on which it reportedly galloped to power in 2009. For the scheme entitling jobs to Below Poverty Line (BPL) households in rural areas, the allocation has been reduced by 17.5 per cent to only...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...